type 2 Diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: An unblinded randomized clinical trial in which women with type 2 diabetes are divided into one of the two following categories:
• intervention group: diabetic patients who received ed
Lifestyle
An unblinded randomized clinical trial in which women with type 2 diabetes are divided into one of the two following categories:
• intervention group: diabetic patients who received education through
An unblinded randomized clinical trial in which women with type 2 diabetes are divided into one of the two following categories:
• control group: diabetic patients who received routine care includes
Sponsors
Endocrinology & Metabolism Research Institute of Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
73 Years to 33 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria Individuals eligible for attending in the study are women with type 2 diabetes who have HbA1c = 8% in the last 6 months. Patients should not plan to migrate out of Tehran during the period of study and research team could easily have been in contact with them. Additionally, following criteria is essential: • Ability to speak in Persian • Age between 20 and 60 years old • To have HbA1c = 8% in the last 6 months • Not be pregnant • Patients with a life expectancy of less than a year and has a serious illness and disease with reduced cognitive capacity approved by the health center staff will be recruited. • Patients who are currently enrolled in a diabetes education programs are not included in the study. exclusion criteria • To have HbA1c equal and above 9% during the study • Become pregnant during the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: HPLC. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting Blood Suger. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: Glocose Oxidase.;Total Cholestrol. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: CHOD-Pap.;Triglyseridi. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: Gpo-pap.;LDL. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: photometery.;HDL. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: photometery.;Body Mass Index. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: weight (kg) / height (m)2.;Blood Pressure. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: Manometer (mmhg).;Waist to Hip Ratio. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: waist hip ratio measurement.;Food intake. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: The three-day recall questionnaire.;Levels of physical activity. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: International Physical Activity Questionnaire (IPAQ.;Self-care activity. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: summery of diabetes self-care activities- SDSCA.;Quality of Life. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: Diabetes Quality of Life (DQOL) Questionnaire.;Depression. Timepoint: Before the intervention and at 3, 6 and 12 months after intervention. Method of measurement: Beck Depression Inventory.;Social Capital. Timepoint: Before the intervention and at 3, 6 and 12 months after interventi | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahnaz Sanjari
Endocrinology and Metabolism Research Institute Tehran University of medical Sciences,Tehran, Iran
Outcome results
None listed